ProfileGDS4718 / 207717_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 94% 67% 94% 96% 91% 90% 96% 95% 97% 96% 93% 96% 91% 94% 95% 96% 91% 94% 74% 94% 94% 96% 95% 95% 88% 95% 87% 96% 91% 92% 93% 96% 96% 94% 90% 93% 95% 95% 14% 97% 90% 89% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.586496
GSM549102patient 115, normal, homogenized [OPG study]10.114494
GSM549104patient 119, normal, homogenized [OPG study]6.6570167
GSM549108patient 138, normal, homogenized [OPG study]10.038494
GSM549119patient 077, normal, homogenized [OPG study]10.5596
GSM549133patient 032, cancer, homogenized [OPG study]9.4429491
GSM549139patient 042, cancer, homogenized [OPG study]9.2446290
GSM549099patient 107, normal, homogenized [OPG study]10.499396
GSM549109patient 139, normal, homogenized [OPG study]10.418595
GSM549110patient 046, normal, homogenized [OPG study]10.922997
GSM549114patient 063, normal, homogenized [OPG study]10.858196
GSM549122patient 082, normal, homogenized [OPG study]9.8561893
GSM549134patient 033, cancer, homogenized [OPG study]10.688196
GSM549136patient 036, cancer, homogenized [OPG study]9.4589591
GSM549140patient 044, cancer, homogenized [OPG study]10.000294
GSM549111patient 047, normal, homogenized [OPG study]10.29395
GSM549113patient 057, normal, homogenized [OPG study]10.824696
GSM549132patient 031, cancer, homogenized [OPG study]9.2650691
GSM549137patient 038, cancer, homogenized [OPG study]9.8741894
GSM549142patient 047, cancer, homogenized [OPG study]7.1593574
GSM549100patient 110, normal, homogenized [OPG study]10.111894
GSM549107patient 135, normal, homogenized [OPG study]10.124694
GSM549115patient 068, normal, homogenized [OPG study]10.745996
GSM549116patient 072, normal, homogenized [OPG study]10.301595
GSM549120patient 078, normal, homogenized [OPG study]10.247295
GSM549131patient 030, cancer, homogenized [OPG study]8.9890988
GSM549118patient 074, normal, homogenized [OPG study]10.289695
GSM549129patient 027, cancer, homogenized [OPG study]8.6242387
GSM549123patient 088, normal, homogenized [OPG study]10.513596
GSM549124patient 006, cancer, homogenized [OPG study]9.1879191
GSM549126patient 015, cancer, homogenized [OPG study]9.4741492
GSM549128patient 025, cancer, homogenized [OPG study]9.7020893
GSM549103patient 117, normal, homogenized [OPG study]10.569496
GSM549117patient 073, normal, homogenized [OPG study]10.820896
GSM549138patient 041, cancer, homogenized [OPG study]10.014394
GSM549141patient 045, cancer, homogenized [OPG study]9.2879690
GSM549130patient 028, cancer, homogenized [OPG study]9.6195193
GSM549101patient 111, normal, homogenized [OPG study]10.241395
GSM549105patient 128, normal, homogenized [OPG study]10.349895
GSM549106patient 134, normal, homogenized [OPG study]3.8963714
GSM549112patient 048, normal, homogenized [OPG study]10.949297
GSM549125patient 011, cancer, homogenized [OPG study]9.0866690
GSM549127patient 024, cancer, homogenized [OPG study]8.9405689
GSM549135patient 035, cancer, homogenized [OPG study]9.3610491